• hit discovery
molecular pharmacology
target identification
hit screening
• lead optimization
property optimization
in vitro
in vivo
• clinical trial
phase I
auto immune
non-opioid painkiller
Our Pipelines
AlphaMol Science
AlphaMol Science advances several "first-in-class" in-house drug discovery projects. The pipelines include dual functional anti-cancer drug,infections, less side effect painkiller, cancer and metabolism.
With the advantages of outstanding GPCR-oriented drug discovery platform in AlphaMol, we managed to speed up the "first-in-class" preclinical drug discovery processes in an ultimately efficient way. The first-in-class lead compounds and PCC molecules are invented within few months. It saves 80-99% costs in both time and finance.